A case study on how DelveInsight helped a pharma client navigate the evolving metabolic dysfunction-associated steatohepatitis (MASH) landsca ...

Senators question Pfizer's partnership with UpScriptHealth, citing potential anti-kickback concerns and risks of increased ...

U.S. District Judge M. Casey Rodgers, accused in a misconduct complaint two weeks ago of showing preference to women, gave ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.

Guggenheim analyst Vamil Divan maintained a Buy rating on Pfizer (PFE – Research Report) yesterday. The company’s shares closed yesterday at ...

The third episode of Marvel Television's new series Daredevil: Born Again was released earlier this week and is receiving ...

CROSBY — Cuyuna Regional Medical Center (CRMC) announces the launch of its refreshed brand identity, marking the culmination of a year-long transformation.

Pfizer and Arvinas' experimental breast cancer treatment failed to delay the progression of the disease in a broader group of ...

VERITAC-2 achieved its primary endpoint in the estrogen receptor 1-mutant population, demonstrating statistically significant and clinically ...

Pharma firms are among many pausing diversity programmes and promising domestic investment ...